Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 12 04:00PM ET
153.90
Dollar change
-1.60
Percentage change
-1.03
%
IndexS&P 500 P/E16.59 EPS (ttm)9.28 Insider Own4.51% Shs Outstand82.62M Perf Week-4.63%
Market Cap12.62B Forward P/E13.55 EPS next Y11.36 Insider Trans-5.58% Shs Float78.30M Perf Month-2.62%
Income827.68M PEG0.93 EPS next Q2.14 Inst Own92.46% Short Float4.82% Perf Quarter-5.91%
Sales12.67B P/S1.00 EPS this Y14.48% Inst Trans-3.36% Short Ratio4.77 Perf Half Y8.26%
Book/sh4.68 P/B32.88 EPS next Y17.13% ROA4.81% Short Interest3.78M Perf Year41.87%
Cash/sh14.39 P/C10.70 EPS next 5Y17.90% ROE104.38% 52W Range103.40 - 169.51 Perf YTD46.91%
Dividend Est.- P/FCF8.86 EPS past 5Y51.82% ROI6.96% 52W High-9.21% Beta0.90
Dividend TTM- Quick Ratio1.33 Sales past 5Y1.27% Gross Margin26.92% 52W Low48.84% ATR (14)3.92
Dividend Ex-Date- Current Ratio1.37 EPS Y/Y TTM45.46% Oper. Margin14.88% RSI (14)40.73 Volatility2.64% 2.34%
Employees70000 Debt/Eq31.54 Sales Y/Y TTM6.34% Profit Margin6.53% Recom2.91 Target Price163.00
Option/ShortYes / Yes LT Debt/Eq29.73 EPS Q/Q-4.59% Payout0.00% Rel Volume0.59 Prev Close155.50
Sales Surprise0.50% EPS Surprise-4.91% Sales Q/Q4.56% EarningsOct 29 AMC Avg Volume791.63K Price153.90
SMA20-4.44% SMA50-2.57% SMA2005.45% Trades Volume463,649 Change-1.03%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Nov-24-24 08:22AM
Nov-15-24 07:08PM
05:14PM
Nov-12-24 09:05AM
12:58AM
04:33PM Loading…
Nov-08-24 04:33PM
Oct-31-24 07:12PM
Oct-30-24 06:38PM
10:05AM
08:46AM
03:14AM
01:02AM
Oct-29-24 11:00PM
05:15PM
04:20PM
04:05PM Loading…
04:05PM
Oct-28-24 11:05AM
Oct-23-24 06:00PM
10:00AM
Oct-22-24 06:15PM
08:00AM
Oct-17-24 01:00PM
Oct-16-24 06:00PM
10:28AM
09:15AM
Oct-14-24 04:28PM
09:40AM
Oct-11-24 03:58PM
Oct-10-24 06:15PM
Oct-09-24 01:47PM
01:38PM Loading…
Oct-08-24 01:38PM
09:45AM
Oct-03-24 06:15PM
08:29AM
Sep-27-24 06:00PM
09:40AM
09:40AM
Sep-26-24 09:50AM
Sep-24-24 06:15PM
12:00PM
09:50AM
Sep-18-24 06:00PM
08:50AM
Sep-17-24 06:15PM
09:00AM
Sep-14-24 11:22AM
Sep-13-24 06:59PM
09:15AM
08:00AM
Sep-12-24 09:40AM
Sep-11-24 06:00PM
09:40AM
Sep-10-24 12:16PM
12:00PM
Sep-06-24 04:00AM
Sep-05-24 11:31AM
Sep-03-24 04:21PM
02:55PM
12:35PM
Aug-30-24 12:00PM
01:23AM
Aug-29-24 01:16AM
Aug-27-24 09:40AM
Aug-26-24 09:40AM
Aug-19-24 11:15PM
Aug-15-24 11:38PM
09:15AM
Aug-14-24 04:01PM
12:00PM
08:05AM
Aug-09-24 01:09AM
Aug-08-24 05:34PM
09:40AM
09:40AM
09:16AM
Aug-07-24 02:30PM
02:21PM
12:55PM
Aug-06-24 09:15PM
05:44PM
05:15PM
04:13PM
04:05PM
Aug-05-24 11:38AM
09:05AM
Jul-30-24 06:00PM
Jul-24-24 06:00PM
Jul-22-24 06:15PM
Jul-18-24 02:00PM
Jul-16-24 06:00PM
12:14PM
10:20AM
Jul-12-24 05:41PM
06:08AM
Jul-10-24 09:40AM
Jul-09-24 06:15PM
Jul-05-24 07:14PM
Jul-04-24 07:29AM
Jun-26-24 06:15PM
09:40AM
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Waters Kathleen AlyceChief Legal & Pub. Affairs OffNov 27 '24Option Exercise108.938,078879,93797,706Nov 27 09:47 PM
Michael StaffieriOfficerNov 27 '24Proposed Sale167.097,9021,320,345Nov 27 03:29 PM
Michael StaffieriOfficerNov 18 '24Proposed Sale157.427,7861,225,664Nov 18 04:27 PM
Michael StaffieriOfficerNov 14 '24Proposed Sale155.947,4591,163,167Nov 14 04:05 PM
ACKERMAN JOELCFO and TreasuerSep 16 '24Option Exercise75.9578,9995,999,974185,740Sep 17 06:08 PM
Rodriguez JavierChief Executive OfficerSep 16 '24Sale165.0550,0008,252,515837,835Sep 17 06:07 PM
Rodriguez JavierChief Executive OfficerSep 13 '24Sale162.859,8811,609,122887,835Sep 17 06:07 PM
Javier RodriguezOfficerSep 16 '24Proposed Sale165.0550,0008,252,514Sep 16 05:47 PM
Michael StaffieriOfficerSep 16 '24Proposed Sale132.4137,2954,938,300Sep 16 05:47 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 28 '24Option Exercise75.9526,3331,999,991109,344Aug 29 06:21 PM
ACKERMAN JOELCFO and TreasuerAug 27 '24Sale155.0664,0299,928,586111,481Aug 29 06:13 PM
ACKERMAN JOELCFO and TreasuerAug 28 '24Sale155.024,740734,785106,741Aug 29 06:13 PM
Rodriguez JavierChief Executive OfficerAug 26 '24Sale155.9332,1765,017,303905,659Aug 28 05:36 PM
Rodriguez JavierChief Executive OfficerAug 27 '24Sale155.937,9431,238,589897,716Aug 28 05:36 PM
Joel AckermanOfficerAug 27 '24Proposed Sale155.0073,64711,415,285Aug 27 04:21 PM
Javier RodriguezOfficerAug 26 '24Proposed Sale155.9350,0007,796,500Aug 26 05:34 PM
NEHRA JOHN Mformer board member Aug 26 '24Proposed Sale153.9030,0004,616,967Aug 26 03:42 PM
Rodriguez JavierChief Executive OfficerAug 20 '24Option Exercise67.80750,00050,850,0001,453,929Aug 22 05:38 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCAug 16 '24Sale150.1732,5804,892,382209,365Aug 19 06:35 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCAug 15 '24Sale150.039,5391,431,126241,945Aug 19 06:35 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffAug 13 '24Sale146.217,8571,148,76683,011Aug 15 06:05 PM
Michael StaffieriOfficerAug 15 '24Proposed Sale150.0142,1196,318,271Aug 15 04:16 PM
Kathleen WatersOfficerAug 13 '24Proposed Sale146.207,8571,148,724Aug 13 04:10 PM
DESOER BARBARA JDirectorMay 10 '24Sale138.815,030698,21410,954May 14 05:44 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMar 13 '24Option Exercise52.4150,0002,620,500102,748Mar 15 06:13 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCMar 06 '24Option Exercise52.4150,0002,620,50087,687Mar 08 05:05 PM
ACKERMAN JOELCFO and TreasuerMar 06 '24Option Exercise52.4155,0002,882,550195,360Mar 08 05:04 PM
Rodriguez JavierChief Executive OfficerMar 06 '24Option Exercise67.80750,00050,850,0001,244,480Mar 08 05:04 PM
Rodriguez JavierChief Executive OfficerFeb 26 '24Option Exercise67.80450,00030,510,000889,002Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 28 '24Option Exercise67.8050,0003,390,000531,300Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 26 '24Sale126.1167,6038,525,130488,697Feb 28 05:51 PM
Rodriguez JavierChief Executive OfficerFeb 27 '24Sale126.877,397938,467481,300Feb 28 05:51 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCFeb 21 '24Option Exercise52.41100,0005,241,000137,687Feb 23 05:44 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCFeb 21 '24Sale119.8129,4883,533,02537,687Feb 23 05:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 21 '24Option Exercise52.4140,0002,096,400121,297Feb 23 05:44 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 21 '24Sale120.7311,2851,362,43881,297Feb 23 05:44 PM
ACKERMAN JOELCFO and TreasuerFeb 21 '24Option Exercise52.4155,0002,882,550178,726Feb 23 05:43 PM
HEARTY JAMES OChief Compliance OfficerFeb 16 '24Option Exercise54.4054,6082,970,47878,448Feb 20 08:37 PM
HEARTY JAMES OChief Compliance OfficerFeb 16 '24Sale119.6426,1643,130,26920,264Feb 20 08:37 PM
Rodriguez JavierChief Executive OfficerDec 14 '23Option Exercise67.80500,00033,900,000833,299Dec 18 06:44 PM